Rabies is a 100% preventable disease. Proper wound management and simultaneous administration of Worab combined with rabies immunoglobulin (RIG) is considered invariably effective in preventing rabies, even after high-risk exposure.

Worab is not recommended for routine use in the general population. It should not be used if a person is moderately or severely ill. If you have any doubts, consult your doctor.

The rabies virus attacks the nervous system (brain and spinal cord). The first symptoms of rabies are similar to a flu-like illness which can be identified as fever, headache and general discomfort. Within days, the disease can progress to symptoms such as anxiety, confusion, agitation, abnormal behavior, delirium and hallucinations.

The rabies virus is transmitted in the saliva of infected animals. People usually become infected with the virus if they get bitten by an infected animal. However, any contact with the saliva of an infected animal (alive or dead) can potentially lead to rabies infection if the person has an opening in the skin or the saliva gets into their eyes, nose or mouth.

Rabies vaccine is recommended for persons in high-risk occupational groups, such as veterinarians and their staff, animal handlers, rabies researchers and certain laboratory workers. International travelers who are likely to come in contact with animals in areas where cases of dog rabies are common. People should remain cautious and must get Worab, especially if they will have limited access to appropriate medical care in such areas.

Yes, Worab can be taken by a pregnant woman. Cases of any fetal abnormalities in pregnant women have not been reported with the use of Worab. The doctor may even suggest routine pre-exposure vaccination against rabies if the risk of exposure is high.

Most of the side effects if Worab are mild, such as soreness and redness at the injection site. Moderate problems, including hives, pain in the joints and fever, are possible in a small percentage of patients (6%) who are given booster doses.